The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine

Cancer Research

Volumn 57, Issue 13, 1997, Pages 2602-2605

  Blay, Jonathan ^a   White, Thomas D ^a   Hoskin, David W ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE KINASE INHIBITOR; COFORMYCIN; TUBERCIDIN DERIVATIVE;

ANIMAL CELL; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; EXTRACELLULAR FLUID; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG CARCINOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; SOLID TUMOR; T LYMPHOCYTE ACTIVATION;

ADENOSINE; ANIMALS; COFORMYCIN; COLONIC NEOPLASMS; ENZYME INHIBITORS; EXTRACELLULAR SPACE; FEMALE; FIBROSARCOMA; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; MICRODIALYSIS; NEOPLASM TRANSPLANTATION; TIME FACTORS; TUBERCIDIN; TUMOR CELLS, CULTURED;

EID: 0030785819     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. 2 cell-surface adenosine receptor. Cell. Immunol., 159: 85-93, 1994.
2. Hoskin, D. W., Reynolds, T., and Blay, J. Adenosine as a possible inhibitor of killer T-cell activation in the microenvironment of solid tumours. Int. J. Cancer, 59: 854-855, 1994.
3. Olsson, R. A., and Pearson, J. D. Cardiovascular purinoceplors. Physiol. Rev., 70: 761-845, 1990.
4. 3 receptor. Cancer Res., 54: 3521-3526, 1994.
5. Williams, B. A., Manzer, A., Blay, J., and Hoskin, D. W. Adenosine acts through a novel extracellular receptor to inhibit granule exocytosis by natural killer cells. Biochem. Biophys. Res. Commun., 231: 264-269, 1997.
6. Parmely, M. J., Zhou, W-W., Edwards, C. K., Borcherding, D. R., Silverstein, R., and Morrison, D. C. Adenosine and a related carbocyclic nucleostde analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J. Immunol., 151: 389-396, 1993.
7. Kinzer, D., and Lehmann, V. Extracellular ATP and adcnosine modulate tumor necrosis factor-induced lysis of L929 cells in the presence of actinomycin D. J. Immunol., 146: 2708-2711, 1991.
8. Sajjadi, F. G., Takabayashi, K., Foster, A. C., Domingo, R. C., and Firestein, G. S. Inhibition of TNF-α expression by adenosine. Role of A3 adenosine receptors. J. Immunol., 156: 3435-3442, 1996.
9. Vaupel, P., Kallinowski, F., and Okunieff, P. Blood flow, oxygen, and nutrient supply, and metabolic microenvironment of human tumours: a review. Cancer Res., 49: 6449-6465, 1989.
10. Stubbs, M., Rodrigues, L., Howe, F. A., Wang, J., Jeong, K. S., Veech, R. L., and Griffiths, J. R. Metabolic consequences of a reversed pH gradient in rat tumours. Cancer Res., 54: 4011-4016, 1994.
11. + and veratridine. J. Neurochem., 45: 791-797, 1985.
12. Lönnroth, P., Jansson, P-A., Fredholm, B. B., and Smith, U. Microdialysis of intercellular adenosine concentration in subcutaneous tissue in humans. Am. J. Physiol., 256: E250-E255, 1989.
13. Ishiwata, S., Itoh, K., Yamaguchi, T., Sasaki, S., Ishida, N., and Mizugaki, M. Serum 1-methyladenosine and pseudouridine as tumor markers in tumor-bearing mice. Yakugaku Zasshi, 115: 523-527, 1995.
14. 6-diethylthioether-N-pyridoximine-5′-phosphate, a circulating human tumor marker. Cancer Res., 56: 3670-3677, 1996.
15. Dewhirst, M. W., Secomb, T. W., Ong, E. T., Hsu, R., and Gross, J. F. Determination of local oxygen consumption rates in tumors. Cancer Res., 54: 3333-3336, 1994.
16. Leith, J. T., Padfield, G., Faulkner, L., and Michelson, S. Hypoxic fractions in xenografted human colon tumors. Cancer Res., 51: 5139-5143, 1991.
17. Castellazzi, M., Minkowski, M., Vielh, P., and Buttin, G. ADA activity levels in IL-2-dependent cultured murine cylotoxic T lymphocytes. Ann. NY Acad. Sci., 451: 308-310, 1985.
18. Dong, R-P., Kameoka, J., Hegen, M., Tanaka, T., Xu, Y., Schlossman, S. F., and Morimoto, C. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J. Immunol., 156: 1349-1355, 1996.
19. Tanaka, T., Kameoka, J., Yaron, A., Schlossman, S. F., and Morimoto, T. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc. Natl Acad. Sci. USA, 90: 4586-4590, 1993.
20. + metabolites. J. Immunol., 157: 1381-1388, 1996.
21. Peola, S., Borrione, P., Matera, L., Malavasi, F., Pileri, A., and Massaia, M. J. Selective induction of CD73 expression in human lymphocytes by CD38 ligation: a novel pathway linking ,signal transducers with ecto-enzymc activities. J. Immunol., 157: 4354-4362, 1996.
22. Thompson, L. F., Ruedi, J. M., Glass, A., Low, M. G., and Lucas, A. H. Antibodies to 5′-nucleotidase (CD73), a glycosyl-phosphalidylinositol-anchored protein, cause human peripheral blood T cells to proliferate. J. Immunol., 143: 1815-1821, 1989.